Form D · Pharmaceuticals
Quoin Pharmaceuticals Ltd.
Ashburn, VA · CIK 0001671502
Offering snapshot reported Sep 10, 2026 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 31, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 10, 2026 | Initial | $50,000,649 | No comparison | 33 | SEC filing |
| Oct 23, 2025 | Initial | $105,254,891 | No comparison | 27 | SEC filing |
| Aug 31, 2022 | Initial | $193,537 | No comparison | 1 | SEC filing |
| Feb 9, 2018 | Initial | $3,999,996 | No comparison | 3 | SEC filing |
| Sep 19, 2017 | Initial | $4,302,202 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-597075
The total offering amount reflects the total gross proceeds to be received assuming cash exercise of all warrants issued in the private placement.
Consists of fees due to placement agents equal in aggregate to 6.0% of gross offering proceeds, assuming cash exercise of all warrants issued. Lead placement agent also entitled to reimbursement for reasonable out-of-pocket expenses, not included here.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Leerink Partners LLC | 000039011 | |
| BTIG, LLC | 000122225 | |
| Lake Street Capital Markets, LLC | 000164447 |
Source: Form D, filed Sep 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ruhama Avraham | Director |
| Ruth Ben Yakar | Director |
| Michael Berelowitz | Director |
| Yuval Berman | Director |
| David Braun | Director |
| Denise Carter | Director, Executive |
| Kasbian Nuriel Chirich | Director |
| Joseph Cooper | Director |
| James Culverwell | Director |
| Gordon Dunn | Executive |
| David Grossman | Director |
| Dennis Langer | Director |
| Sally Bridget Lawlor | Executive |
| Eyal Leibovitz | Executive |
| Natalie Leong | Director |
| Michael Myers | Director, Executive |
| Abraham Nahmias | Director |
| Michael Sember | Director |
| Shai Yarkoni | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
42127 Pleasant Forest Court
Ashburn, VA, 20148-7349
Phone: (703) 980-4182
Ashburn, VA, 20148-7349
Phone: (703) 980-4182